Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1

BACKGROUND: Immunotherapy is currently under investigation in B3 Thymoma (TB3) and Thymic Carcinoma (TC). PD-L1 expression has been evaluated on a limited number of patients with selected antibodies. We aimed to analyze cohort of TB3 and TC with a panel of antibodies to assess the prevalence of PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouquette, Isabelle, Taranchon-Clermont, Estelle, Gilhodes, Julia, Bluthgen, Maria-Virginia, Perallon, Romain, Chalabreysse, Lara, De Muret, Anne, Hofman, Veronique, Marx, Alexander, Parrens, Marie, Secq, Veronique, Thomas de Montpreville, Vincent, Galateau-Salle, Françoise, Brousset, Pierre, Milia, Julie, Girard, Nicolas, Besse, Benjamin, Molina, Thierry Jo, Mazières, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894111/
https://www.ncbi.nlm.nih.gov/pubmed/31827799
http://dx.doi.org/10.1186/s40364-019-0177-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894111/
https://www.ncbi.nlm.nih.gov/pubmed/31827799
http://dx.doi.org/10.1186/s40364-019-0177-8

Ejemplares similares